Search In this Thesis
   Search In this Thesis  
العنوان
COLLAGEN CROSS-LINKING FOR THE TREATMENT OF INFECTIOUS KERATITIS/
المؤلف
EL SHERBINY,REHAM FAWZY
هيئة الاعداد
باحث / ريهام فوزى الشربيني
مشرف / سعد محمد رشاد
مشرف / عبد الرحمن جابرسالمان
مشرف / محمد شفيق الألفى
تاريخ النشر
2016
عدد الصفحات
126.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب العيون
تاريخ الإجازة
1/1/2016
مكان الإجازة
جامعة عين شمس - كلية الطب - Ophthalmology
الفهرس
Only 14 pages are availabe for public view

from 126

from 126

Abstract

Microbes develop resistance to antibiotics as a result of chromosomal mutation, inductive expression of latent chromosomal genes, or exchange of genetic material via transformation, bacteriophage transduction, or plasmid conjugation. Some microbial keratitis resistant to the newest antibiotics have been recently described.
A considerable amount of research is directed toward developing newer antibiotics or defining alternative methods of treatment. Corneal degradation and melting occurs when specific proteinases are upregulated after corneal damage. These matrix metalloproteinases are synthesized either in the keratocytes (matrix metalloproteinase 2) or by corneal epithelial cells (matrix metalloproteinase 9) and are also responsible for delayed epithelial wound healing.
Corneal collagen cross-linking (CXL) is a novel technique used for the treatment of keratoconus (KC) and postoperative ectasia using ultraviolet-A (UV-A) and riboflavin to increase the biomechanical strength of the cornea thus giving it possibilities to block the progression of KC.